Matches in Nanopublications for { ?s ?p "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- NP65489.RAgMwjtTAYLTBNTDaDM5RgJzc9svi_Hc4pRzAHC1D6wd4130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP65489.RAgMwjtTAYLTBNTDaDM5RgJzc9svi_Hc4pRzAHC1D6wd4130_provenance.
- NP65500.RAkYan9g8JJdwkjreAjwb-A2xIDfdbSbvLVDy_JVS13OI130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP65500.RAkYan9g8JJdwkjreAjwb-A2xIDfdbSbvLVDy_JVS13OI130_provenance.
- NP65515.RAu63pdNcQI1WDClQyJCc3H-RXKeqvEQ5vWwt82U6pjj0130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP65515.RAu63pdNcQI1WDClQyJCc3H-RXKeqvEQ5vWwt82U6pjj0130_provenance.
- NP65521.RAihreFEl12oJ9sMYkQKADZLWcUVpcx-bIadQ6c22cy_c130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP65521.RAihreFEl12oJ9sMYkQKADZLWcUVpcx-bIadQ6c22cy_c130_provenance.
- NP71363.RAZkcmlvwwLuBbpvB051L__IlIykBuu9FA3liRJoF2qeU130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP71363.RAZkcmlvwwLuBbpvB051L__IlIykBuu9FA3liRJoF2qeU130_provenance.
- NP65496.RABbENdmP21iD-upGo-CYt79sVorv1yDGrWHkY02fflzY130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP65496.RABbENdmP21iD-upGo-CYt79sVorv1yDGrWHkY02fflzY130_provenance.
- NP65519.RAOT7RuAbygM-WIAbGJ-J3uBVDrLb79WoTGhlFM_leXLg130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP65519.RAOT7RuAbygM-WIAbGJ-J3uBVDrLb79WoTGhlFM_leXLg130_provenance.
- NP65510.RAaLImCBbsJ6uSrYcnWay8CLwzJ8laF3tBT8_TAliskwQ130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP65510.RAaLImCBbsJ6uSrYcnWay8CLwzJ8laF3tBT8_TAliskwQ130_provenance.
- NP65523.RAUE2-DI9-2eKivOyONUFjV_in4_tcho9O1Fh4Pc70erM130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP65523.RAUE2-DI9-2eKivOyONUFjV_in4_tcho9O1Fh4Pc70erM130_provenance.
- NP66977.RAUnyHr5n1A9WNGI98c1WqFYDBQukKFy9wTIEfQipYu6U130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP66977.RAUnyHr5n1A9WNGI98c1WqFYDBQukKFy9wTIEfQipYu6U130_provenance.
- NP78772.RAcmSQ7SUqj8PMacIfQOfCBK7qsF9kl5iJ3Q904QkmPic130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP78772.RAcmSQ7SUqj8PMacIfQOfCBK7qsF9kl5iJ3Q904QkmPic130_provenance.
- NP78812.RAf0l9gbVEGz_CDVGSpMF2MZShvG2NzaVdBkAo5L8HMPo130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP78812.RAf0l9gbVEGz_CDVGSpMF2MZShvG2NzaVdBkAo5L8HMPo130_provenance.
- NP65498.RAy2bJtpLyjhH4VTBOLfSXSQb8KDZSQuvkq5JM4H07AEI130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP65498.RAy2bJtpLyjhH4VTBOLfSXSQb8KDZSQuvkq5JM4H07AEI130_provenance.
- NP65503.RA2Ykhos0284aNMfvEmFBxuq3nv-VdLC-WfDP9OZlOEes130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP65503.RA2Ykhos0284aNMfvEmFBxuq3nv-VdLC-WfDP9OZlOEes130_provenance.
- NP71263.RA52gxSLvVcpM2ww5dkNJI7Ef7IythEDrolYLvY8nOYwI130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP71263.RA52gxSLvVcpM2ww5dkNJI7Ef7IythEDrolYLvY8nOYwI130_provenance.
- NP117088.RAWZucm9gBJw98ArrchtWHkbEHqSsfFPW_LZ8KypDbKzA130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP117088.RAWZucm9gBJw98ArrchtWHkbEHqSsfFPW_LZ8KypDbKzA130_provenance.
- NP84763.RAUY5jbv8gpoid2KQXjIa-qoEPfaRfw5gd3TIroTh2c8U130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84763.RAUY5jbv8gpoid2KQXjIa-qoEPfaRfw5gd3TIroTh2c8U130_provenance.
- NP84783.RAAfTIKiFifLk_TjgVz0GTJTZG6UfDGLkFtwN0SoVjm20130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84783.RAAfTIKiFifLk_TjgVz0GTJTZG6UfDGLkFtwN0SoVjm20130_provenance.
- NP84751.RA3n17m848aPkhvvX22N7jUH9w80tP0HN9gxcKd9dBFnM130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84751.RA3n17m848aPkhvvX22N7jUH9w80tP0HN9gxcKd9dBFnM130_provenance.
- NP84767.RAxx_7ddV-YYSpGA-EP58EGdNg5Q5MCRYMOhcGMm4vhKs130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84767.RAxx_7ddV-YYSpGA-EP58EGdNg5Q5MCRYMOhcGMm4vhKs130_provenance.
- NP84770.RA978gS8BLzofNxrRDzajoYr_EY4lLE_Vx1D13j6OUruU130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84770.RA978gS8BLzofNxrRDzajoYr_EY4lLE_Vx1D13j6OUruU130_provenance.
- NP84802.RA6fmVuavDUn2ugkbc6eulcCg2NBTlAyWT4Osiyiiqrac130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84802.RA6fmVuavDUn2ugkbc6eulcCg2NBTlAyWT4Osiyiiqrac130_provenance.
- NP147627.RAA_7JaeRmgYvdfNQRY0RqQNxmPjtYa9qk_qFeu6asNKA130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147627.RAA_7JaeRmgYvdfNQRY0RqQNxmPjtYa9qk_qFeu6asNKA130_provenance.
- NP147633.RAAzPL_u_GaQ4P1BflP7KjhDv7DSD2xqmpImB9xJSI6ZU130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147633.RAAzPL_u_GaQ4P1BflP7KjhDv7DSD2xqmpImB9xJSI6ZU130_provenance.
- NP147626.RA3KAq2VnUBDW1-Wiulw5FKwCMkydP9MCMdfVNp0JqAEM130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147626.RA3KAq2VnUBDW1-Wiulw5FKwCMkydP9MCMdfVNp0JqAEM130_provenance.
- NP147630.RA_vr2NFsVMv3gcK0MwZ3PP4sWD64a0--F_nnVguSxznw130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147630.RA_vr2NFsVMv3gcK0MwZ3PP4sWD64a0--F_nnVguSxznw130_provenance.
- NP147634.RA0G5jW0fCKTHzqyxivB_5Z461eJivQJhC0jIgXOB8c4k130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147634.RA0G5jW0fCKTHzqyxivB_5Z461eJivQJhC0jIgXOB8c4k130_provenance.
- assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP84796.RAlfkACBXvTt16uLZU4nUhg5W20jwsrIjwy6tngcPuBHY130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84796.RAlfkACBXvTt16uLZU4nUhg5W20jwsrIjwy6tngcPuBHY130_provenance.
- NP84799.RAsk08uZwVufqLfFjsIketsTXoMZIiY0pfSn0R1cBLlCk130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84799.RAsk08uZwVufqLfFjsIketsTXoMZIiY0pfSn0R1cBLlCk130_provenance.
- NP117170.RAOPL-Q3-U9rWda0YtP5jQZQTWPPR701-l18TgB5vdiTg130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP117170.RAOPL-Q3-U9rWda0YtP5jQZQTWPPR701-l18TgB5vdiTg130_provenance.
- NP147621.RAacg4AueDStW_aY9cl39jDN0chnt7Ti6a-kqLWnexxpQ130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147621.RAacg4AueDStW_aY9cl39jDN0chnt7Ti6a-kqLWnexxpQ130_provenance.
- NP147632.RAanNGO0yJvUC9q_Qht9vl_QpULFXzjoUw3FQiAE7aprk130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147632.RAanNGO0yJvUC9q_Qht9vl_QpULFXzjoUw3FQiAE7aprk130_provenance.
- NP96908.RAKkPVFMmiOGbRiIAFHBvuaDpS4qLt_GEGnNgiqELAeEo130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96908.RAKkPVFMmiOGbRiIAFHBvuaDpS4qLt_GEGnNgiqELAeEo130_provenance.
- assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP96715.RAlxA0yN4DKYJkO9xPRl1PouOlMvwQ1qYqWISNVfZSvIM130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96715.RAlxA0yN4DKYJkO9xPRl1PouOlMvwQ1qYqWISNVfZSvIM130_provenance.
- assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP147620.RAIopFBukhbL5WgpD1UVMUIYIFTvUcMqRHsXGDb4SLQy4130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147620.RAIopFBukhbL5WgpD1UVMUIYIFTvUcMqRHsXGDb4SLQy4130_provenance.
- NP147623.RAGThNYb90dJEWHE1eZBe7DTNH2MUWeRnsfWfRVG07XzI130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147623.RAGThNYb90dJEWHE1eZBe7DTNH2MUWeRnsfWfRVG07XzI130_provenance.
- NP147628.RAPckf6I1NrYzsZ0aoKBkQij4-rqr3vYSgorxTU7fAGv0130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147628.RAPckf6I1NrYzsZ0aoKBkQij4-rqr3vYSgorxTU7fAGv0130_provenance.
- NP147636.RAEcqRt-5b9PkPP3mLn9j1vpyye__E4yFest49BPTM1UA130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147636.RAEcqRt-5b9PkPP3mLn9j1vpyye__E4yFest49BPTM1UA130_provenance.
- assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP147622.RAol_hvbBRY63f_wVpJQHggdNKrM-sW1Ez4LHRcXj5lco130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147622.RAol_hvbBRY63f_wVpJQHggdNKrM-sW1Ez4LHRcXj5lco130_provenance.